ArticleFrontiers in oncology2026

High feasibility and safety of office-based transurethral laser ablation for recurrent non-muscle invasive bladder cancer: a single-center experience.

Zoran Zimak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.